Raymond James Financial Inc Veracyte, Inc. Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 205,328 shares of VCYT stock, worth $7.32 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
205,328
Previous 213,074
3.64%
Holding current value
$7.32 Million
Previous $6.32 Million
12.14%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
295Shares Held
77.2MCall Options Held
0Put Options Held
17.6K-
Vanguard Group Inc Valley Forge, PA8.1MShares$289 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$278 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$187 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.8MShares$135 Million0.85% of portfolio
-
Wellington Management Group LLP Boston, MA3.47MShares$124 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.55B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...